Coming off a string of disappointing recent quarters, Mood Media (Stock Quote, Chart, News: TSX:MM) says it may sell the company.
In a press release this afternoon, the company said its board has formed a strategic review committee to review a range of options to enhance shareholder value, including the potential sale of the company. Mood Media has engaged engaged Credit Suisse and Morgan Stanley as financial advisers.
Late in March, the company reported its fiscal 2012 results. On the back of several recent acquisitions, the company’s topline keeps growing, but so are its losses. Mood Media lost $79.23-million on revenue of $443.8-million, up from a loss of $59.90-million and revenue of $274.7-million a year prior.
Byron Capital analyst Rob Goff, who cut his price target on Mood Media following the Q4 numbers, says he is concerned by the delay in the company profitably transitioning its legacy audio business into customers on the video side.
Mood Media came to public attention when it completed the $345 million acquisition of Muzak, forming an entity that had $400 million in revenue in what is referred to as the sensory branding space, a term for multi-sensory marketing tactics now being used by giants such as Nissan, Pizza Hut and Starbucks. The company has inked deals with brands as diverse as Vitamin Shoppe, Hooter’s and the Puma store in Paris, where the company installed giant video walls.
Shares of MM were halted today after market close, but ended the day up 4.2% to $.99.
Following first quarter results that were cheered by the street, CIBC analyst Todd Coupland has maintained his "Buy" rating and… [Read More]
Hydreight Technologies (Hydreight Technologies Stock Quote, Chart, News, Analysts, Financials TSXV:NURS) is accelerating its efforts to build what it calls… [Read More]
Roth Capital Markets analyst Darren Aftahi raised his price target on TeraWulf (TeraWulf Stock Quote, Chart, News, Analysts, Financials NASDAQ:WULF)… [Read More]
Haywood Capital Markets analyst Gianluca Tucci raised his target price on Tornado Infrastructure Equipment (Tornado Infrastructure Equipment Stock Quote, Chart,… [Read More]
Research Capital analyst Andre Uddin maintained a “Buy” rating and C$5.55 price target on Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote,… [Read More]
Roth Capital Markets analyst Eric Handler maintained a “Buy” rating and $164 price target on Live Nation (Live Nation Stock… [Read More]